Trimethoprim-sulfamethoxazole and risk of sudden death among patients taking spironolactone
. .
Compared with amoxicillin, trimethoprim-sulfamethoxazole was associated with a twofold increase of sudden death (adjusted OR 2.46, 95 % CI 1.55-3.90) as a consequence of hyperkalemia in this population-based study of patients over the age of 65 on spironolactone.
Related Articles:
- Trimethoprim-Sulfamethoxazole-Induced Hyperkalemia in Patients Receiving Inhibitors of the Renin-Angiotensin System: A Population-Based Study
- ESRD and Death after Heart Failure in CKD
- Vascular Access Type and Patient and Technique Survival in Home Hemodialysis Patients: The Canadian Organ Replacement Register.
Recent Comments